Schedule 13D ownership disclosure

KALOBIOS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 48344T209

Event date: 2016-06-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-16-643415
Form type
SC 13D/A
Filer
HUMANIGEN, INC
CIK
CIK 1293310
Filed
Jul 07, 2016
Reporting period
Jun 29, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub